We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Italian Firm Acquires Fast Melt Technology

By Biotechdaily staff writers
Posted on 07 Feb 2003
The worldwide rights to a new pharmaceutical fast melt technology and manufacturing process have been acquired by Eurand (Milan, Italy) under an agreement with Kyowa Hakko Kogyo Co., Ltd. More...
(Tokyo, Japan).

The new fast melt technology will allow patients to take their medications anytime, anywhere without chewing or the need for water. The technology produces an orally administered fast-dissolving dosage form and is broadly applicable, since it can be used with both soluble and insoluble products. The tablet is produced using a proprietary system that utilizes 10-30 times less hydrophobic lubricant than conventional tablet production. The resulting tablet is both hard and durable but does not impede liquid entry upon contact with saliva. In addition, the tablet does not contain water-insensitive cohesive bonds between particles to hinder disintegration. Eurand intends to market the products in combination with Microcaps, the company's taste-masking technology.

"This technology is different from the competition in that while it offers a first class fast melt tablet in terms of speed of disintegration, it is both easy to produce and more robust than other fast melt tablets,” noted Gearoid Faherty, CEO of Eurand.





Related Links:
Eurand
Kyowa

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Hematology Consumables
Bioblood Devices
New
Repetitive Pipette
VWR® Stepper Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: An elevated neutrophil-to-lymphocyte ratio (NLR), a rato easily obtained from a routine blood count, was associated with both short- and long-term Alzheimer’s risk (photo credit: 123RF)

Routine Blood Count Ratio Linked to Future Alzheimer’s and Dementia Risk

Alzheimer’s disease and related dementias develop over years, making it difficult to identify at-risk patients before symptoms appear. Clinicians therefore need widely available laboratory markers that... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.